Position
Chief Technology Officer
Company
Auregen Biotherapeutics
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Auregen Biotherapeutics has announced the appointment of Scott Lauder, Ph.D., as Chief Technology Officer. Dr. Lauder brings deep expertise in innovative technologies and biologic modalities, and will play a crucial role in advancing the Phase 1/2 study for AUR-201, the company's first-in-class therapeutic ear replacement for people with microtia.
Quick answer
Auregen Appoints Scott Lauder, Ph.D., as Chief Technology Officer (March 26, 2025). Auregen Biotherapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Technology Officer at Auregen Biotherapeutics?
- Auregen Biotherapeutics named Scott Lauder Chief Technology Officer, announced March 26, 2025.
- What did Auregen Biotherapeutics announce on March 26, 2025?
- Auregen Biotherapeutics has announced the appointment of Scott Lauder, Ph.D., as Chief Technology Officer. Dr. Lauder brings deep expertise in innovative technologies and biologic modalities, and will play a crucial role in advancing the Phase 1/2 study for AUR-201, the company's first-in-class therapeutic ear replacement for people with microtia.
- What does Auregen Biotherapeutics do?
- Auregen is a pioneering clinical-stage company developing precision approaches to restore functional anatomy with cartilage cell therapy.
- Where is Auregen Biotherapeutics based?
- Auregen Biotherapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Verrica (March 26, 2025), Byondis B.V (March 25, 2025), Repare Therapeutics (April 1, 2025) and Dyne Therapeutics (March 20, 2025) also announced leadership changes within 45 days of Auregen Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer (March 26, 2025)
- Byondis Appoints Christoph Korpus as Chief Business Officer (CBO) (March 25, 2025)
- Repare Therapeutics Appoints Steve Forte as President and CEO (April 1, 2025)
- Dyne Therapeutics Appoints Erick J. Lucera as Chief Financial Officer (March 20, 2025)
- Nanoscope Therapeutics Appoints Ademola Daramola as Vice President, Quality and Compliance (March 20, 2025)
- VectorY Therapeutics Appoints Olga Uspenskaya-Cadoz as Chief Medical Officer (April 1, 2025)
Who to call at Auregen Biotherapeutics, and when
A new leader at Auregen Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Auregen Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Auregen Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Auregen Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Auregen Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Auregen Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.